Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Selected renal cells modulate disease progression in rodent models of chronic kidney disease via NF-κB and TGF-β1 pathways.

Bruce AT, Ilagan RM, Guthrie KI, Rivera E, Choudhury S, Sangha N, Spencer T, Bertram TA, Jain D, Kelley RW, Basu J.

Regen Med. 2015;10(7):815-39. doi: 10.2217/rme.15.43. Epub 2015 Nov 16.

PMID:
26568079
2.

Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms.

Basu J, Assaf BT, Bertram TA, Rao M.

Toxicol Pathol. 2015 Jan;43(1):115-25. doi: 10.1177/0192623314559104. Epub 2014 Dec 4. Review.

PMID:
25476796
3.

Cell-based therapeutic products: potency assay development and application.

Basu J, Ludlow JW.

Regen Med. 2014;9(4):497-512. doi: 10.2217/rme.14.25.

PMID:
25159066
4.

Enhancing tissue engineering/regenerative medical product commercialization: the role of science in regulatory decision making for tissue engineering/regenerative medicine product development.

Bertram TA, Johnson PC, Tawil B, Van Dyke M, Hellman KB.

Tissue Eng Part A. 2013 Nov;19(21-22):2313. doi: 10.1089/ten.TEA.2013.0536. Epub 2013 Oct 11. No abstract available. Erratum in: Tissue Eng Part A. 2013 Dec;19(23-24):2735.

PMID:
24059530
5.

Potency evaluation of tissue engineered and regenerative medicine products.

Guthrie K, Bruce A, Sangha N, Rivera E, Basu J.

Trends Biotechnol. 2013 Sep;31(9):505-14. doi: 10.1016/j.tibtech.2013.05.007. Epub 2013 Aug 6. Review.

PMID:
23932143
6.

Cross-linked gelatin microspheres with continuously tunable degradation profiles for renal tissue regeneration.

Serban MA, Knight T, Payne RG, Basu J, Rivera EA, Robbins N, McCoy D, Halberstadt C, Jain D, Bertram TA.

Biotechnol Appl Biochem. 2014 Mar-Apr;61(2):75-81. doi: 10.1002/bab.1125. Epub 2013 Oct 22.

PMID:
23692609
7.

Fabrication of a multi-layer three-dimensional scaffold with controlled porous micro-architecture for application in small intestine tissue engineering.

Knight T, Basu J, Rivera EA, Spencer T, Jain D, Payne R.

Cell Adh Migr. 2013 May-Jun;7(3):267-74. doi: 10.4161/cam.24351. Epub 2013 Apr 5.

8.

Histological evaluation of tissue regeneration using biodegradable scaffold seeded by autologous cells for tubular/hollow organ applications.

Rivera EA, Jayo MJ.

Methods Mol Biol. 2013;1001:353-74. doi: 10.1007/978-1-62703-363-3_29.

PMID:
23494443
9.

Genotypic and phenotypic analysis of in vivo tissue regeneration in an animal model.

Genheimer CW.

Methods Mol Biol. 2013;1001:341-51. doi: 10.1007/978-1-62703-363-3_28.

PMID:
23494442
10.

Tissue engineering of esophagus and small intestine in rodent injury models.

Basu J, Mihalko KL, Rivera EA, Guthrie KI, Genheimer CW, Sangha N, Ludlow JW.

Methods Mol Biol. 2013;1001:311-24. doi: 10.1007/978-1-62703-363-3_26.

PMID:
23494440
11.

Bioreactor design considerations for hollow organs.

Fish J, Halberstadt C, McCoy DW, Robbins N.

Methods Mol Biol. 2013;1001:207-14. doi: 10.1007/978-1-62703-363-3_18.

PMID:
23494432
12.

Migration assay to evaluate cellular interactions with biomaterials for tissue engineering/regenerative medicine applications.

Guthrie KI, Sangha N, Genheimer CW, Basu J, Ludlow JW.

Methods Mol Biol. 2013;1001:189-96. doi: 10.1007/978-1-62703-363-3_16.

PMID:
23494430
13.

Characterization of a PGA-based scaffold for use in a tissue-engineered neo-urinary conduit.

Knight TA, Payne RG.

Methods Mol Biol. 2013;1001:179-88. doi: 10.1007/978-1-62703-363-3_15.

PMID:
23494429
14.

Design, fabrication, and preparation of synthetic scaffolds for urologic tissue engineering.

Payne RG, Knight TA.

Methods Mol Biol. 2013;1001:167-77. doi: 10.1007/978-1-62703-363-3_14.

PMID:
23494428
15.

Phenotypic analysis of bioactive cells for application in regenerative medicine.

Burnette TB, Bruce AT.

Methods Mol Biol. 2013;1001:115-32. doi: 10.1007/978-1-62703-363-3_10.

PMID:
23494424
16.

Ex vivo culture and separation of functional renal cells.

Bruce AT, Guthrie KI, Kelley R.

Methods Mol Biol. 2013;1001:53-64. doi: 10.1007/978-1-62703-363-3_6.

PMID:
23494420
17.

Isolation of urothelial cells from bladder tissue.

Sangha N.

Methods Mol Biol. 2013;1001:21-33. doi: 10.1007/978-1-62703-363-3_3.

PMID:
23494417
18.

Isolation of smooth muscle cells from bladder for generation of engineered urologic organs.

McCoy DW.

Methods Mol Biol. 2013;1001:13-20. doi: 10.1007/978-1-62703-363-3_2.

PMID:
23494416
19.

The regulatory imperative: international perspective.

Bertram T, Hellman KB, Bayon Y, Ellison S, Wilburn S.

Tissue Eng Part B Rev. 2013 Jun;19(3):191-3. doi: 10.1089/ten.TEB.2012.0654. Epub 2013 Jan 30. No abstract available.

PMID:
23216282
20.

A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathy.

Kelley R, Bruce A, Spencer T, Werdin E, Ilagan R, Choudhury S, Rivera E, Wallace S, Guthrie K, Jayo M, Xu F, Rao AN, Humphreys BD, Presnell S, Bertram T.

Cell Transplant. 2013;22(6):1023-39. doi: 10.3727/096368912X653237. Epub 2012 Aug 10.

PMID:
22889490

Supplemental Content

Loading ...
Support Center